Murphy Pohlad Asset Management LLC Moderna, Inc. Transaction History

Murphy Pohlad Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$85.37 - $115.44 $4,268 - $5,772	-50 Reduced 2.44%	2,000 $213,000
Q4 2023 Jan 19, 2024	BUY	$69.51 - $104.43 $3,475 - $5,221	50 Added 2.5%	2,050 $203,000
Q3 2023 Oct 10, 2023	SELL	$96.41 - $126.61 $20,728 - $27,221	-215 Reduced 9.71%	2,000 $206,000
Q3 2022 Oct 24, 2022	BUY	$118.07 - $194.18 $261,525 - $430,108	2,215 New	2,215 $261,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.